Literature DB >> 3951693

Spinal angiography with iohexol.

B Kendall.   

Abstract

Iohexol 300 was used for 55 selective spinal angiograms in 50 patients; all were of good quality. There was no significant change in vital signs during the angiographic procedure in any case. Two patients with spinal dural arteriovenous fistula draining into a coronal venous plexus developed transient subjective slight increase in their disability during the immediate post-angiographic period. Eight cases embolised at the time of angiography showed improvement in their neurological deficits within 24 h of the study. The other patients were unaffected by the procedure. Iohexol 300 is a very suitable contrast medium for spinal angiography.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3951693     DOI: 10.1007/bf00341771

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

1.  The pathophysiology of spinal vascular malformations.

Authors:  M J Aminoff; R O Barnard; V Logue
Journal:  J Neurol Sci       Date:  1974-10       Impact factor: 3.181

2.  Excitation and depression of non-anaesthetized rabbits following injection of contrast media into the subarachnoid space.

Authors:  K Golman; H Olivecrona; C Gustafson; S Salvesen; T Almén; P Maly
Journal:  Acta Radiol Suppl       Date:  1980

3.  Tolerance to iohexol after intracisternal, intracerebral and intraarterial injection in the rat.

Authors:  H M Siefert; W R Press; U Speck
Journal:  Acta Radiol Suppl       Date:  1980

4.  Iohexol in cerebral angiography. Survey and present state.

Authors:  S Cronqvist
Journal:  Acta Radiol Suppl       Date:  1983
  4 in total
  1 in total

1.  Endovascular and surgical treatment of spinal dural arteriovenous fistulas.

Authors:  Robert H Andres; Alain Barth; Raphael Guzman; Luca Remonda; Marwan El-Koussy; Rolf W Seiler; Hans R Widmer; Gerhard Schroth
Journal:  Neuroradiology       Date:  2008-06-28       Impact factor: 2.804

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.